Synergistic effect between doxorubicin and a low dose of all-trans-retinoic acid in MCF-7 breast cancer cell line

Cancer Letters

Volumn 116, Issue 1, 1997, Pages 103-110

  Toma, Salvatore ^a,c   Maselli, Giuseppina ^b,c   Dastoli, Giuseppe ^d,e   De Francisci, Elena ^c   Raffo, Patrizia ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Advanced Biotechnology Center ABC   (Italy)

^d ROCHE MILANO RICERCHE   (Italy)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

All trans retinoic acid; Breast cancer; Doxorubicin; Synergistic effect

Indexed keywords

ANTIMITOTIC AGENT; DOXORUBICIN; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; HUMANS; RECEPTORS, ESTROGEN; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030994358     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00169-9     Document Type: Article

References (20)

1. Haskell, C.M. (1995). Systemic treatment for metastatic breast cancer. In: Cancer Treatment, pp. 354-368. Editor: C.M. Haskell. Saunders, Philadelphia, PA.
2. Lown, J.W. (1985) Molecular mechanisms of action of anticancer agents involving free radical intermediates, Free Rad. Biol. Med., 1, 225-264.
3. Sporn, M.B. and Roberts, A.B. (1983) Role of retinoids in differentiation and carcinogenesis, Cancer Res., 43, 3034-3040.
4. Lotan, R. (1979) Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition, Cancer Res., 39, 1014-1019.
5. Monn, R.C., Mehta, R.G. and Detrisac, C.J. (1992) Retinoids as chemopreventive agents for breast cancer, Cancer Detect. Prev., 16 (1), 73-79.
6. Kurie, J.M., Lippmann, S.M. and Hong, W.K. (1994) Potential of retinoids in cancer prevention, Cancer Treat. Rev., 20, 1-10.
7. Lacroix, A. and Lippman, M.E. (1980) Binding of retinoids to human breast cancer cell lines and their effects on cell growth, J. Clin. Invest., 65, 586-591.
8. Ueda, H., Takenawa, T., Millan, J.C., Gesell, M.S. and Brandes, D. (1980) The effect of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells, Cancer (Philadelphia), 46, 2203-2209.
9. Toma, S., Isnardi, L., Raffo, P., Dastoli, G., De Francisci, E., Riccardi, L., Palumbo, R., and Bollag, W. (1997) Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast cancer cell lines: growth inhibition and apoptosis induction. Int. J. Cancer, 70, in press.
10. Sinha, B.K., Katki, A.G., Batist, G., Cowan, K.H. and Myers, C.E. (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells, Biochem. Pharmacol., 36, 793-796.
11. Doroshow, J. (1986) Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents, Biochem. Biophys. Res. Commun., 135, 330-335.
12. Wetherall, N.T. and Taylor, C.M. (1986) The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells, Eur. J. Cancer Clin. Oncol., 22 (1), 53-59.
13. Marth, C., Bock, G. and Daxenbichler, G. (1985) Effects of 4-hydroxyphenyl retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells, J. Natl. Cancer Inst., 75 (5), 871-875.
14. Toma, S., Monteghirfo, S., Tasso, P., Nicolò, G., Spadini, N., Palumbo, R. and Molina, F. (1994) Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines, Cancer Lett., 82, 209-216.
15. Sacks, P.G., Harris, D. and Chou, T.-C. (1995) Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents, Int. J. Cancer, 61, 409-415.
16. Doyle, L.A., Giangiulo, D., Hussain, A., Park, H.-J., Yen, R.-W.C. and Borges, M. (1989) Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid, Cancer Res., 49, 6745-6751.
17. Ruppert, K.L., Masters, J.R.W., Kneuchel, R., Seegers, S., Tain-sky, M.A., Hofstaedter, F. and Buettner, R. (1992) The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene, Int. J. Cancer, 51, 646-651.
18. Prutkin, L. (1992) Antitumor activity of vitamin A acid and fluorouracil used in combination on the skin tumor, keratocarcinoma, Cancer Res., 33, 128-133.
19. Komiyama, S., Hiroto, I., Ryu, S., Nakashima, T., Kuwano, M. and Endo, H. (1978) Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumors, Oncology, 35, 253-257.
20. Thatcher, N., Blackledge, G. and Crowther, D. (1980) Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate and vitamin A, Cancer, 46, 1324-1328.